Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the effectiveness of MR-HIFU for the treatment of uterine fibroids in Northwestern Ontario, which is a rural and remote setting.


Clinical Trial Description

Uterine fibroids are benign smooth muscle tumours of the muscular wall of the uterus that affect 40 per cent of women. While the majority of fibroids are asymptomatic, fibroids may cause menorrhagia, bulk symptoms (i.e. ureteric obstruction, urinary frequency and urgency, bowel dysfunction), pain and in certain instances infertility.

Magnetic resonance image-guided high-intensity focused ultrasound (MR-HIFU) treatment of fibroids is an established method for symptom alleviation with over 3000 women receiving treatment worldwide. MR-HIFU is a non-invasive, non-surgical procedure that uses ultrasound energy to thermally ablate the fibroid leading to a reduction in bleeding and in the size of uterine fibroids over time. MR-HIFU it is not currently being used for the treatment of symptomatic fibroids in Canada.

The Thunder Bay Regional Research Institute has one of the first clinically available MR-HIFU equipment in Canada. In order to bring this technology into clinical practice, a knowledge translation study is needed to demonstrate that MR-HIFU can treat symptomatic uterine fibroids as successfully in Northwestern Ontario compared to urban centres where all of the clinical trials have been conducted. The ability to screen and follow up women treated with MR-HIFU with ultrasound rather than MRI would allow participants to receive follow up in regional centres in Northwestern Ontario and it would be more cost effective from a health system perspective. In addition, more research is needed to broaden the scope of treatment to include fibroids greater than 8 cm such that more women could benefit from this non-surgical fibroid management option. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02736435
Study type Interventional
Source Thunder Bay Regional Research Institute
Contact
Status Withdrawn
Phase Phase 3
Start date January 18, 2018
Completion date January 18, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Not yet recruiting NCT03219385 - Directed Ablation of Uterine Fibroids Using a Noninvasive Approach N/A
Completed NCT01338831 - Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer Phase 1
Completed NCT01468402 - Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma N/A
Completed NCT03847077 - Trial of a Patient Education Tool For Leiomyoma N/A
Completed NCT00365989 - MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Phase 3
Completed NCT03751124 - Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Phase 3
Recruiting NCT02495311 - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Completed NCT04874246 - Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy N/A
Not yet recruiting NCT04282863 - Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM) N/A
Recruiting NCT06115408 - Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma Phase 2/Phase 3
Completed NCT02059954 - Vaginal vs. Laparoscopic Hysterectomy N/A
Completed NCT02049242 - Uterine Tourniquet at Open Myomectomy N/A
Terminated NCT01738724 - Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin Phase 4
Terminated NCT01280045 - Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy N/A
Completed NCT04819633 - Evaluating Serum Sestrin in Leiomyoma Patients
Completed NCT00341848 - Postpartum Uterine Regression
Completed NCT01715597 - Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma Phase 3
Completed NCT03328260 - High Intensity Focused Ultrasound in Uterine Myoma N/A